Pon Holdings-backed URUS completed the acquisition of Recombinetics.

Synopsis

Pon Holdings-backed URUS, a software company, completed the acquisition of Recombinetics, a company focused on proprietary gene repair and gene-editing technology. Financial terms were not disclosed.

Principals

target

RECOMBINETICS

bidder

Urus Group

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

morgan lewis & bockius

HQ - Philadelphia

legal advisors

bidder

912

Deals

£ 323.87 B

Total Value